Sort by
Keyphrases
Narcolepsy
94%
Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD)
77%
Polysomnography
71%
Obstructive Sleep Apnea
55%
Rapid Eye Movement Sleep
43%
Hypocretin
37%
Parkinson's Disease
37%
Sleep Disorders
28%
Sleep Disturbance
28%
REM Sleep
28%
Melatonin
28%
Sleep Quality
27%
Sleep Apnea
26%
Rheumatoid Arthritis
25%
Healthy Controls
23%
Sleep-disordered Breathing
23%
Denmark
23%
Randomized Controlled Trial
23%
Confidence Interval
21%
Snoring
21%
Electroencephalography
20%
Insomnia
18%
Economic Consequences
17%
Comorbidity
17%
Sleep Stages
17%
Epilepsy
17%
Disturbed Sleep
17%
Control Subjects
16%
Circadian Rhythm
16%
Actigraphy
16%
Arousal
15%
Rapid Eye Movement
15%
Health Consequences
14%
Socio-economic Impact
14%
Europe
14%
Cerebrospinal Fluid
14%
Health Care Costs
14%
Social Consequences
14%
Register Study
13%
Cluster Headache
13%
Parkinson Patients
13%
Patients with Parkinson's Disease
13%
Critically Ill Patients
13%
Continuous Positive Airway Pressure
13%
Wakefulness
12%
Childhood-onset
12%
Sleep Staging
12%
Neurodegenerative Diseases
12%
Copenhagen
11%
Positive Airway Pressure Therapy
11%
Neuroscience
Rapid Eye Movement Sleep
100%
Narcolepsy
73%
Obstructive Sleep Apnea
70%
Parkinson's Disease
51%
Behavior Disorder
46%
Polysomnography
44%
Sleep Disorder
44%
Rapid Eye Movement Sleep Behavior Disorder
37%
Orexin
29%
Melatonin
28%
Sleep Stage
26%
Sleep Quality
22%
Hypersomnia
18%
Orexin-A
18%
Electroencephalography
17%
Electroencephalography
16%
Actigraphy
16%
Cataplexy
16%
Somnolence
14%
Wakefulness
13%
Circadian Rhythm
12%
Daytime Somnolence
12%
Cluster Headache
12%
Sleep Time
11%
Limb Movement
11%
Neurodegenerative Disorder
11%
Non-Rapid Eye Movement Sleep
11%
Randomized Controlled Trial
10%
Benzodiazepine
10%
Sleep Spindle
10%
Transcranial Magnetic Stimulation
10%
Neural Network
10%
Electroencephalogram
9%
Rheumatoid Arthritis
9%
Eye Movement
8%
Meta-Analysis
8%
Cortisol
8%
Sleep Pattern
8%
Body Mass Index
8%
Electromyography
8%
Cognitive Behavioral Therapy
8%
Epileptic Absence
7%
Psychoactive Drug
7%
Neurodegeneration
7%
Restless Legs Syndrome
7%
Dementia Praecox
7%
Cognitive Disorders
7%
Motor Evoked Potential
6%
Placebo
6%
Hypothalamus
6%
